FDA Announces Guidance for Blood Collection from Individuals with Hereditary Hemochromatosis

Summary

The Food and Drug Administration (FDA) has released a guidance document outlining alternative procedures for blood collection from individuals with hereditary hemochromatosis, allowing for variances to current regulations without labeling the donor's disease on the container or collecting blood more frequently without a physician's certification.